Tonix Pharmaceuticals Holding (TNXP) Finished Goods (2023 - 2025)
Historic Finished Goods for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $1.8 million.
- Tonix Pharmaceuticals Holding's Finished Goods fell 3309.27% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 3309.27%. This contributed to the annual value of $5.1 million for FY2024, which is 3157.97% down from last year.
- Per Tonix Pharmaceuticals Holding's latest filing, its Finished Goods stood at $1.8 million for Q3 2025, which was down 3309.27% from $2.4 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Finished Goods ranged from a high of $7.5 million in Q4 2023 and a low of $1.8 million during Q3 2025
- In the last 3 years, Tonix Pharmaceuticals Holding's Finished Goods had a median value of $3.7 million in 2024 and averaged $4.0 million.
- As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Finished Goods plummeted by 3157.97% in 2024, and later tumbled by 3309.27% in 2025.
- Tonix Pharmaceuticals Holding's Finished Goods (Quarter) stood at $7.5 million in 2023, then plummeted by 31.58% to $5.1 million in 2024, then plummeted by 65.63% to $1.8 million in 2025.
- Its Finished Goods stands at $1.8 million for Q3 2025, versus $2.4 million for Q2 2025 and $4.8 million for Q1 2025.